FTC Submits Amicus Brief Explaining that Drug Companies Use No-Authorized Generic Agreements to Delay Generic Competition
Date
The Federal Trade Commission filed an amicus brief in the U.S. District Court for the District of New Jersey stating that an agreement by a branded drug company not to launch an authorized generic (AG...